Last reviewed · How we verify
Deficiency of testosterone biosynthesis
Approved treatments
- Xyosted (Autoinjector) · Endo
- Androgel · Besins Hlthcare
- Testosterone Cypionate · Azurity
- Testosteron · Gulhane School of Medicine
- Anamidol
Anamidol binds to androgen receptors in the body, triggering a cascade of downstream effects that promote muscle growth and development. - Fluotestin
- Testosterone cypionate (200mg/3ml) · Leticia Maria Defendi Barboza Marson
- Testred · Bausch Health
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Deficiency of testosterone biosynthesis patent landscape — cliff calendar, originator estates, attackable patents
- Deficiency of testosterone biosynthesis treatment landscape brief
- Deficiency of testosterone biosynthesis treatment updates RSS
Frequently asked questions about Deficiency of testosterone biosynthesis
What drugs treat Deficiency of testosterone biosynthesis?
Tracked treatments include Xyosted (Autoinjector), Androgel, Testosterone Cypionate, Testosteron, Anamidol, Fluotestin, Testosterone cypionate (200mg/3ml), Testred.
What is the treatment for Deficiency of testosterone biosynthesis?
Standard treatment for Deficiency of testosterone biosynthesis includes Xyosted (Autoinjector), Androgel, Testosterone Cypionate, Testosteron, Anamidol. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Deficiency of testosterone biosynthesis patent cliff · Deficiency of testosterone biosynthesis CI report
- Treatment: Xyosted (Autoinjector) · Endo
- Treatment: Androgel · Besins Hlthcare
- Treatment: Testosterone Cypionate · Azurity
- Treatment: Testosteron · Gulhane School of Medicine
- Treatment: Anamidol
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing